Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
14.90
+0.21 (1.43%)
Oct 4, 2024, 4:00 PM EDT - Market closed

Assembly Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-45.61-61.23-93.09-129.86-62.15-97.63
Upgrade
Depreciation & Amortization
0.260.450.50.475.914.95
Upgrade
Loss (Gain) From Sale of Assets
0.140.14--1.380.010.1
Upgrade
Asset Writedown & Restructuring Costs
---41.641.75-
Upgrade
Loss (Gain) From Sale of Investments
-3.59-1.590.160.59-0.01-1.74
Upgrade
Stock-Based Compensation
3.675.126.595.2421.8520.56
Upgrade
Other Operating Activities
2.513.513.511.31--0.78
Upgrade
Change in Accounts Receivable
0.340.9-0.610.892.14-0.94
Upgrade
Change in Accounts Payable
-0.1-2.03-0.17-1.942.87-1.96
Upgrade
Change in Unearned Revenue
69.2483.56--6.25-28.06-3.61
Upgrade
Change in Other Net Operating Assets
-2.53-6.09-1.35-4.1-7.26-3.01
Upgrade
Operating Cash Flow
24.3322.74-84.46-93.4-62.96-84.07
Upgrade
Capital Expenditures
-0.24-0.26-0.1-3.1-0.47-1.55
Upgrade
Sale of Property, Plant & Equipment
0.020.021.52.36--
Upgrade
Sale (Purchase) of Intangibles
-----1.75-
Upgrade
Investment in Securities
-48.18-68.9189.2427.2570.29-48.76
Upgrade
Investing Cash Flow
-48.39-69.1490.6426.5268.07-50.32
Upgrade
Issuance of Common Stock
21.6513.820.6153.067.6139.65
Upgrade
Financing Cash Flow
21.6513.820.6153.067.6139.65
Upgrade
Net Cash Flow
-2.42-32.586.79-13.8212.715.26
Upgrade
Free Cash Flow
24.122.49-84.57-96.49-63.43-85.62
Upgrade
Free Cash Flow Margin
112.18%313.95%--1542.88%-80.18%-536.37%
Upgrade
Free Cash Flow Per Share
4.634.91-20.96-26.75-21.48-39.13
Upgrade
Levered Free Cash Flow
5.5-8.2-48.91-62.75-10.96-42.72
Upgrade
Unlevered Free Cash Flow
5.5-8.2-48.91-62.75-10.96-42.72
Upgrade
Change in Net Working Capital
-33.39-26.89-2.237.6-0.431.53
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.